In the last trading session, 1.28 million C4 Therapeutics Inc (NASDAQ:CCCC) shares changed hands as the company’s beta touched 2.97. With the company’s per share price at $1.38 changed hands at $0.0 or 0.00% during last session, the market valuation stood at $97.99M. CCCC’s last price was a discount, traded about -455.07% off its 52-week high of $7.66. The share price had its 52-week low at $1.09, which suggests the last value was 21.01% up since then.
Analysts gave the C4 Therapeutics Inc (CCCC) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended CCCC as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
C4 Therapeutics Inc (NASDAQ:CCCC) trade information
The company’s shares are showing year-to-date downside of -61.67%, with the 5-day performance at -6.12% in the red. However, in the 30-day time frame, C4 Therapeutics Inc (NASDAQ:CCCC) is 25.45% up.
The consensus price target for the stock as assigned by Wall Street analysts is 12, meaning bulls need an upside of 88.5% from its current market value. According to analyst projections, CCCC’s forecast low is 12 with 12 as the target high. To hit the forecast high, the stock’s price needs a -769.57% plunge from its current level, while the stock would need to soar -769.57% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.92%. The 2025 estimates are for C4 Therapeutics Inc earnings to decrease by -11.89%, but the outlook for the next 5-year period is at 6.55% per year.
CCCC Dividends
C4 Therapeutics Inc is expected to release its next quarterly earnings report in June.
RA CAPITAL MANAGEMENT, L.P. holds the second largest percentage of outstanding shares, with 7.0891% or 4.88 million shares worth $22.54 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were WASATCH FUNDS TRUST-Wasatch Ultra Growth Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 4.56 shares estimated at $6.29 million under it, the former controlled 6.42% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.92% of the shares, roughly 2.07 shares worth around $2.86 million.
